MedImmune Jabbed With $15M Flu Vaccine Royalty Suit

Law360, New York (June 16, 2010, 1:05 PM EDT) -- Mount Sinai School of Medicine of New York University has sued MedImmune LLC for failing to pay at least $15 million in royalties allegedly owed on sales of the H1N1 flu vaccine to the U.S. government.

The complaint, launched Tuesday in the Supreme Court of New York, claims MedImmune has breached a licensing agreement and denied the medical school its share of a $428 million vaccine contract with the U.S. Department of Health and Human Services.

MedImmune, an AstraZeneca PLC subsidiary, developed and manufactured the H1N1...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.